Akero Therapeutics, Inc. Increase (Decrease) in Deferred Charges
Akero Therapeutics, Inc. reported Increase (Decrease) in Deferred Charges of -$337.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2025-02-28
- Akero Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2023-12-31 was $0.00.
- Akero Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2023-09-30 was $0.00.
- Akero Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2023-06-30 was $0.00.
- Akero Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2023-03-31 was -$337.00K.
- Akero Therapeutics, Inc. increase (decrease) in deferred charges for fiscal 2023 was -$337.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | -$337.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | -$337.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$337.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$337.00K 10-Q · filed 2024-05-10 |